Question special

I would be interested to hear from the authors and from practicing clinicians regarding the safety of this study. Is there anything further they would do in clinical practice to try to avoid adverse outcomes? The safety data is outlined in detail in the supplementary data, tables S4 and S5 and show increased rates of gastroenteritis, lower respiratory track infection, eczema, immune system disorders, and myopia in the "avoiders" group. Any other comments or concerns about safety?